A carbon nanotube-polymer composite for T-cell therapy

Nature Nanotechnology

Volumn 9, Issue 8, 2014, Pages 639-647

  Fadel, Tarek R ^a   Sharp, Fiona A ^a   Vudattu, Nalini ^b   Ragheb, Ragy ^a   Garyu, Justin ^b   Kim, Dongin ^a   Hong, Enping ^a   Li, Nan ^a   Haller, Gary L ^a   Pfefferle, Lisa D ^a   Justesen, Sune ^c   Harold, Kevin C ^b   Fahmy, Tarek M ^a,b  

^a Yale University   (United States)

^b YALE UNIVERSITY   (United States)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CARBON NANOTUBES; COMPOSITE MATERIALS; CYTOLOGY; DISEASES; MAGNETITE; MAGNETITE NANOPARTICLES; MAMMALS; ONCOLOGY; POLYMERS; YARN;

ARTIFICIAL ANTIGEN; ARTIFICIAL SUBSTRATES; CANCER IMMUNOTHERAPY; CANCER THERAPY; CLINICAL TRANSLATION; HIGH SURFACE AREA; INTERLEUKIN-2; POLYMER NANOPARTICLES;

T-CELLS;

CARBON NANOTUBE; CARBON NANOTUBE POLYMER; INTERLEUKIN 2; MAGNETITE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG; ANTIGEN; IMMOBILIZED PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL INTERACTION; CELL ISOLATION; CELL THERAPY; COMPOSITE MATERIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; MAGNETIC SEPARATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TOPOGRAPHY; TUMOR CELL INOCULATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BIOLOGICAL THERAPY; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; IMMUNOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; ANTIGENS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; HUMANS; IMMOBILIZED PROTEINS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; MELANOMA; MICE; NANOTUBES, CARBON; POLYMERS; T-LYMPHOCYTES;

EID: 84905864143     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2014.154     Document Type: Article

References (45)

1. Waldmann, T. A. Immunotherapy: Past, present and future. Nature Med. 9, 269-277 (2003
2. Dudley, M. E. & Rosenberg, S. A. Adoptive-cell-Transfer therapy for the treatment of patients with cancer. Nature Rev. Cancer 3, 666-675 (2003
3. Zemon, H. An artificial solution for adoptive immunotherapy. Trends Biotechnol. 21, 418-420 (2003
4. Brentjens, R. J. et al. CD19-Targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Science Transl. Med. 5, 177ra38 (2013
5. Robbins, P. F. et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917-924 (2011
6. Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509-1518 (2013
7. Murphy, K., Travers, P. & Walport, M. Janeway's Immunobiology (Garland Science, 2008
8. Kim, J. V., Latouche, J.-B., Rivière, I. & Sadelain, M. The ABCs of artificial antigen presentation. Nature Biotechnol. 22, 403-410 (2004
9. Steenblock, E. R., Wrzesinski, S. H., Flavell, R. A. & Fahmy, T. M. Antigen presentation on artificial acellular substrates: Modular systems for flexible, adaptable immunotherapy. Expert Opin. Biol. Ther. 9, 451-464 (2009
10. Kropshofer, H. et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nature Immunol. 3, 61-68 (2002
11. Fooksman, D. R., Grönvall, G. K., Tang, Q. & Edidin, M. Clustering class I MHC modulates sensitivity of T cell recognition. J. Immunol. 176, 6673-6680 (2006
12. Andersen, P. S., Menné, C., Mariuzza, R. A., Geisler, C. & Karjalainen, K. A response calculus for immobilized T cell receptor ligands. J. Biol. Chem. 276, 49125-49132 (2001
13. González, P. A. et al. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc. Natl Acad. Sci. USA 102, 4824-4829 (2005
14. Grakoui, A. et al. The immunological synapse: A molecular machine controlling T cell activation. Science 285, 221-227 (1999
15. Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86 (1998
16. Cemerski, S. et al. The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse. Immunity 26, 345-355 (2007
17. Li, Q.-J. et al. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nature Immunol. 5, 791-799 (2004
18. Oelke, M. et al. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. NatureMed. 9, 619-624 (2003
19. Prakken, Bet al. Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'. Nature Med. 6, 1406-1410 (2000
20. Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell derived exosomes. Nature Med. 4, 594-600 (1998
21. Steenblock, E. R. & Fahmy, T. M. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells. Mol. Ther. 16, 765-772 (2008
22. Oosten, L. E. M. et al. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. Blood 104, 224-226 (2004
23. Sabatos, C. A. et al. A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction. Immunity 29, 238-248 (2008
24. Huse, M., Quann, E. J. & Davis, M. M. Shouts, whispers and the kiss of death: Directional secretion in T cells. Nature Immunol. 9, 1105-1111 (2008
25. Ye, Q. et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J. Transl. Med. 9, 131 (2011
26. Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453-479 (2008
27. Fadel, T. R. & Fahmy, T. M. Immunotherapy applications of carbon nanotubes: From design to safe applications. Trends Biotechnol. 32, 198-209 (2014
28. Zanello, L P., Zhao, B., Hu, H. & Haddon, R. C. Bone cell proliferation on carbon nanotubes. Nano Lett. 6, 562-567 (2006
29. Nayak, T. R. et al. Thin films of functionalized multiwalled carbon nanotubes as suitable scaffold materials for stem cells proliferation and bone formation. ACS Nano 4, 7717-7725 (2010
30. Steenblock, E. R., Fadel, T., Labowsky, M., Pober, J. S. & Fahmy, T. M. An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response. J. Biol. Chem. 286, 34883-34892 (2011
31. Chen, Y et al. Low-defect, purified, narrowly (n, m)-dispersed single-walled carbon nanotubes grown fromcobalt-incorporatedMCM-41. ACS Nano 1, 327-336 (2007
32. Fadel, T. R. et al. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett. 8, 2070-2076 (2008
33. Fadel, T. R. et al. Adsorption of multimeric T cell antigens on carbon nanotubes: Effect on protein structure and antigen-specific T cell stimulation. Small 9, 666-672 (2013
34. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994
35. Fadel, T. R. et al. Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation. Langmuir 26, 5645-5654 (2010
36. Park, J. et al. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates. J. Control. Rel. 156, 109-115 (2011
37. Fahmy, T. M., Samstein, R. M., Harness, C. C. & Mark Saltzman, W. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26, 5727-5736 (2005
38. Ragheb, R. R. T. et al. Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics. Magn. Reson. Med. 70, 1748-1760 (2013
39. Cheng, L. E., Ohlén, C., Nelson, B. H. & Greenberg, P. D. Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death. Proc. Natl Acad. Sci. USA 99, 3001-3006 (2002
40. Labowsky, M. & Fahmy, T. M. Diffusive transfer between two intensely interacting cells with limited surface kinetics. Chem. Eng. Sci. 74, 114-123 (2012
41. Janas, M. L., Groves, P., Kienzle, N. & Kelso, A. IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J. Immunol. 175, 8003-8010 (2005
42. Rabinovich, G. A., Gabrilovich, D. & Sotomayor, E. M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267-296 (2007
43. Pardoll, D. M. Spinning molecular immunology into successful immunotherapy. Nature Rev. Immunol. 2, 227-238 (2002
44. Suter, D. M. & Krause, K-H. Neural commitment of embryonic stem cells: Molecules, pathways and potential for cell therapy. J. Pathol. 215, 355-368 (2008
45. McIntosh, K. et al. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells 24, 1246-1253 (2006.